Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial

AP Kappetein, TE Feldman, MJ Mack… - European heart …, 2011 - academic.oup.com
Aims Long-term randomized comparisons of percutaneous coronary intervention (PCI) to
coronary artery bypass grafting (CABG) in left main coronary (LM) disease and/or three …

Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the …

AP Kappetein, KD Dawkins, FW Mohr… - European journal of …, 2006 - academic.oup.com
Objective: Percutaneous coronary intervention with drug-eluting stents is challenging
coronary artery bypass grafting (CABG) as the gold standard for treatment of three-vessel …

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease …

DJ Cohen, RL Osnabrugge, EA Magnuson, K Wang… - Circulation, 2014 - Am Heart Assoc
Background—The Synergy Between Percutaneous Coronary Intervention With TAXUS and
Cardiac Surgery (SYNTAX) trial demonstrated that in patients with 3-vessel or left main …

Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass …

MC Morice, PW Serruys, AP Kappetein, TE Feldman… - Circulation, 2010 - Am Heart Assoc
Background—The prospective, multinational, randomized Synergy Between Percutaneous
Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial was designed to …

Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between …

MC Morice, PW Serruys, AP Kappetein, TE Feldman… - Circulation, 2014 - Am Heart Assoc
Background—Current guidelines recommend coronary artery bypass graft surgery (CABG)
when treating significant de novo left main coronary artery (LM) stenosis; however …

Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …

MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - thelancet.com
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …

Ten-year outcomes after drug-eluting stents versus coronary artery bypass grafting for left main coronary disease: extended follow-up of the PRECOMBAT trial

DW Park, JM Ahn, H Park, SC Yun, DY Kang, PH Lee… - Circulation, 2020 - Am Heart Assoc
Background: Long-term comparative outcomes after percutaneous coronary intervention
(PCI) with drug-eluting stents and coronary-artery bypass grafting (CABG) for left main …

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up …

FW Mohr, MC Morice, AP Kappetein, TE Feldman… - The lancet, 2013 - thelancet.com
Background We report the 5-year results of the SYNTAX trial, which compared coronary
artery bypass graft surgery (CABG) with percutaneous coronary intervention (PCI) for the …

Left main stenting in comparison with surgical revascularization: 10-year outcomes of the (left main coronary artery stenting) LE MANS trial

PE Buszman, PP Buszman… - Cardiovascular …, 2016 - jacc.org
Objectives This study has reported 10-year clinical follow-up of patients enrolled in the
prospective, randomized LE MANS (Left Main Stenting) trial. Background The very long-term …

Drug-eluting stent for left main coronary artery disease: the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary …

A Chieffo, E Meliga, A Latib, SJ Park, Y Onuma… - JACC: Cardiovascular …, 2012 - jacc.org
Objectives: The aim of this study was to compare, in a large all-comers registry, major
adverse cardiac and cerebrovascular events (MACCE) after percutaneous coronary …